Global Gene Therapy on Neurological Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 60

Published Date: 09 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

According to our (Global Info Research) latest study, the global Gene Therapy on Neurological Diseases market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Gene Therapy on Neurological Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Gene Therapy on Neurological Diseases market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Therapy on Neurological Diseases market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Therapy on Neurological Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Therapy on Neurological Diseases market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy on Neurological Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy on Neurological Diseases market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis and Sarepta Therapeutics. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Gene Therapy on Neurological Diseases market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Viral Gene Therapy
    Non-viral Gene Therapy

Market segment by Application
    Hospital
    Clinic
    Other

Market segment by players, this report covers
    Biogen
    Novartis
    Sarepta Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy on Neurological Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy on Neurological Diseases, with revenue, gross margin and global market share of Gene Therapy on Neurological Diseases from 2018 to 2023.
Chapter 3, the Gene Therapy on Neurological Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy on Neurological Diseases market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy on Neurological Diseases.
Chapter 13, to describe Gene Therapy on Neurological Diseases research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy on Neurological Diseases
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy on Neurological Diseases by Type
        1.3.1 Overview: Global Gene Therapy on Neurological Diseases Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Type in 2022
        1.3.3 Viral Gene Therapy
        1.3.4 Non-viral Gene Therapy
    1.4 Global Gene Therapy on Neurological Diseases Market by Application
        1.4.1 Overview: Global Gene Therapy on Neurological Diseases Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global Gene Therapy on Neurological Diseases Market Size & Forecast
    1.6 Global Gene Therapy on Neurological Diseases Market Size and Forecast by Region
        1.6.1 Global Gene Therapy on Neurological Diseases Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Gene Therapy on Neurological Diseases Market Size by Region, (2018-2029)
        1.6.3 North America Gene Therapy on Neurological Diseases Market Size and Prospect (2018-2029)
        1.6.4 Europe Gene Therapy on Neurological Diseases Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Gene Therapy on Neurological Diseases Market Size and Prospect (2018-2029)
        1.6.6 South America Gene Therapy on Neurological Diseases Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Gene Therapy on Neurological Diseases Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Gene Therapy on Neurological Diseases Product and Solutions
        2.1.4 Biogen Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Gene Therapy on Neurological Diseases Product and Solutions
        2.2.4 Novartis Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Sarepta Therapeutics
        2.3.1 Sarepta Therapeutics Details
        2.3.2 Sarepta Therapeutics Major Business
        2.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product and Solutions
        2.3.4 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Sarepta Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy on Neurological Diseases Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Gene Therapy on Neurological Diseases by Company Revenue
        3.2.2 Top 3 Gene Therapy on Neurological Diseases Players Market Share in 2022
        3.2.3 Top 6 Gene Therapy on Neurological Diseases Players Market Share in 2022
    3.3 Gene Therapy on Neurological Diseases Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy on Neurological Diseases Market: Region Footprint
        3.3.2 Gene Therapy on Neurological Diseases Market: Company Product Type Footprint
        3.3.3 Gene Therapy on Neurological Diseases Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy on Neurological Diseases Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Gene Therapy on Neurological Diseases Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2018-2023)
    5.2 Global Gene Therapy on Neurological Diseases Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2029)
    6.2 North America Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2029)
    6.3 North America Gene Therapy on Neurological Diseases Market Size by Country
        6.3.1 North America Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2029)
        6.3.2 United States Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        6.3.3 Canada Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        6.3.4 Mexico Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2029)
    7.2 Europe Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2029)
    7.3 Europe Gene Therapy on Neurological Diseases Market Size by Country
        7.3.1 Europe Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2029)
        7.3.2 Germany Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        7.3.3 France Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        7.3.5 Russia Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        7.3.6 Italy Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Region (2018-2029)
        8.3.2 China Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        8.3.3 Japan Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        8.3.4 South Korea Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        8.3.5 India Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        8.3.7 Australia Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2029)
    9.2 South America Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2029)
    9.3 South America Gene Therapy on Neurological Diseases Market Size by Country
        9.3.1 South America Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2029)
        9.3.2 Brazil Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        9.3.3 Argentina Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2029)
        10.3.2 Turkey Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)
        10.3.4 UAE Gene Therapy on Neurological Diseases Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Gene Therapy on Neurological Diseases Market Drivers
    11.2 Gene Therapy on Neurological Diseases Market Restraints
    11.3 Gene Therapy on Neurological Diseases Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Gene Therapy on Neurological Diseases Industry Chain
    12.2 Gene Therapy on Neurological Diseases Upstream Analysis
    12.3 Gene Therapy on Neurological Diseases Midstream Analysis
    12.4 Gene Therapy on Neurological Diseases Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy on Neurological Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Gene Therapy on Neurological Diseases Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Gene Therapy on Neurological Diseases Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Gene Therapy on Neurological Diseases Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Biogen Company Information, Head Office, and Major Competitors
    Table 6. Biogen Major Business
    Table 7. Biogen Gene Therapy on Neurological Diseases Product and Solutions
    Table 8. Biogen Gene Therapy on Neurological Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Biogen Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Gene Therapy on Neurological Diseases Product and Solutions
    Table 13. Novartis Gene Therapy on Neurological Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 16. Sarepta Therapeutics Major Business
    Table 17. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product and Solutions
    Table 18. Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Sarepta Therapeutics Recent Developments and Future Plans
    Table 20. Global Gene Therapy on Neurological Diseases Revenue (USD Million) by Players (2018-2023)
    Table 21. Global Gene Therapy on Neurological Diseases Revenue Share by Players (2018-2023)
    Table 22. Breakdown of Gene Therapy on Neurological Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 23. Market Position of Players in Gene Therapy on Neurological Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 24. Head Office of Key Gene Therapy on Neurological Diseases Players
    Table 25. Gene Therapy on Neurological Diseases Market: Company Product Type Footprint
    Table 26. Gene Therapy on Neurological Diseases Market: Company Product Application Footprint
    Table 27. Gene Therapy on Neurological Diseases New Market Entrants and Barriers to Market Entry
    Table 28. Gene Therapy on Neurological Diseases Mergers, Acquisition, Agreements, and Collaborations
    Table 29. Global Gene Therapy on Neurological Diseases Consumption Value (USD Million) by Type (2018-2023)
    Table 30. Global Gene Therapy on Neurological Diseases Consumption Value Share by Type (2018-2023)
    Table 31. Global Gene Therapy on Neurological Diseases Consumption Value Forecast by Type (2024-2029)
    Table 32. Global Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2023)
    Table 33. Global Gene Therapy on Neurological Diseases Consumption Value Forecast by Application (2024-2029)
    Table 34. North America Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2023) & (USD Million)
    Table 35. North America Gene Therapy on Neurological Diseases Consumption Value by Type (2024-2029) & (USD Million)
    Table 36. North America Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2023) & (USD Million)
    Table 37. North America Gene Therapy on Neurological Diseases Consumption Value by Application (2024-2029) & (USD Million)
    Table 38. North America Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2023) & (USD Million)
    Table 39. North America Gene Therapy on Neurological Diseases Consumption Value by Country (2024-2029) & (USD Million)
    Table 40. Europe Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2023) & (USD Million)
    Table 41. Europe Gene Therapy on Neurological Diseases Consumption Value by Type (2024-2029) & (USD Million)
    Table 42. Europe Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2023) & (USD Million)
    Table 43. Europe Gene Therapy on Neurological Diseases Consumption Value by Application (2024-2029) & (USD Million)
    Table 44. Europe Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2023) & (USD Million)
    Table 45. Europe Gene Therapy on Neurological Diseases Consumption Value by Country (2024-2029) & (USD Million)
    Table 46. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2023) & (USD Million)
    Table 47. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Type (2024-2029) & (USD Million)
    Table 48. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2023) & (USD Million)
    Table 49. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Application (2024-2029) & (USD Million)
    Table 50. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Region (2018-2023) & (USD Million)
    Table 51. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value by Region (2024-2029) & (USD Million)
    Table 52. South America Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2023) & (USD Million)
    Table 53. South America Gene Therapy on Neurological Diseases Consumption Value by Type (2024-2029) & (USD Million)
    Table 54. South America Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2023) & (USD Million)
    Table 55. South America Gene Therapy on Neurological Diseases Consumption Value by Application (2024-2029) & (USD Million)
    Table 56. South America Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2023) & (USD Million)
    Table 57. South America Gene Therapy on Neurological Diseases Consumption Value by Country (2024-2029) & (USD Million)
    Table 58. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Type (2018-2023) & (USD Million)
    Table 59. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Type (2024-2029) & (USD Million)
    Table 60. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Application (2018-2023) & (USD Million)
    Table 61. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Application (2024-2029) & (USD Million)
    Table 62. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Country (2018-2023) & (USD Million)
    Table 63. Middle East & Africa Gene Therapy on Neurological Diseases Consumption Value by Country (2024-2029) & (USD Million)
    Table 64. Gene Therapy on Neurological Diseases Raw Material
    Table 65. Key Suppliers of Gene Therapy on Neurological Diseases Raw Materials
List of Figures
    Figure 1. Gene Therapy on Neurological Diseases Picture
    Figure 2. Global Gene Therapy on Neurological Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Type in 2022
    Figure 4. Viral Gene Therapy
    Figure 5. Non-viral Gene Therapy
    Figure 6. Global Gene Therapy on Neurological Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Gene Therapy on Neurological Diseases Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Picture
    Figure 9. Clinic Picture
    Figure 10. Other Picture
    Figure 11. Global Gene Therapy on Neurological Diseases Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Gene Therapy on Neurological Diseases Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Gene Therapy on Neurological Diseases Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Gene Therapy on Neurological Diseases Consumption Value Market Share by Region in 2022
    Figure 16. North America Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Gene Therapy on Neurological Diseases Revenue Share by Players in 2022
    Figure 22. Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Gene Therapy on Neurological Diseases Market Share in 2022
    Figure 24. Global Top 6 Players Gene Therapy on Neurological Diseases Market Share in 2022
    Figure 25. Global Gene Therapy on Neurological Diseases Consumption Value Share by Type (2018-2023)
    Figure 26. Global Gene Therapy on Neurological Diseases Market Share Forecast by Type (2024-2029)
    Figure 27. Global Gene Therapy on Neurological Diseases Consumption Value Share by Application (2018-2023)
    Figure 28. Global Gene Therapy on Neurological Diseases Market Share Forecast by Application (2024-2029)
    Figure 29. North America Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Gene Therapy on Neurological Diseases Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Gene Therapy on Neurological Diseases Consumption Value (2018-2029) & (USD Million)
    Figure 63. Gene Therapy on Neurological Diseases Market Drivers
    Figure 64. Gene Therapy on Neurological Diseases Market Restraints
    Figure 65. Gene Therapy on Neurological Diseases Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Gene Therapy on Neurological Diseases in 2022
    Figure 68. Manufacturing Process Analysis of Gene Therapy on Neurological Diseases
    Figure 69. Gene Therapy on Neurological Diseases Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Biogen
Novartis
Sarepta Therapeutics

Related Reports

Global Gene Therapy on Neurological Diseases Supply, Demand and Key Producers, 2023-2029

Global Gene Therapy on Neurological Diseases Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

The global Gene Therapy on Neurological Diseases market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Gene Therapy on Neurological Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gene Therapy on Neurological Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gene Therapy on Neurological Diseases market size was valued at USD 4472.8 million in 2023 and is forecast to a readjusted size of USD 12130 million by 2030 with a CAGR of 15.3% during review period.

Global Gene Therapy on Neurological Diseases Supply, Demand and Key Producers, 2024-2030

Global Gene Therapy on Neurological Diseases Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

The global Gene Therapy on Neurological Diseases market size is expected to reach $ 12130 million by 2030, rising at a market growth of 15.3% CAGR during the forecast period (2024-2030).

Product Tags

Gene Therapy on Neurological Diseases

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>